Article citationsMore>>

Gao, X., Tian, N., Kan, J., Li, P., Wang, M., Sheiban, I., et al. (2025) Drug-Coated Balloon Angioplasty of the Side Branch during Provisional Stenting: The Multicenter Randomized DCB-BIF Trial. Journal of the American College of Cardiology, 85, 1-15.
https://doi.org/10.1016/j.jacc.2024.08.067

has been cited by the following article:

• TITLE: Research Progress of Drug-Coated Balloons in the Treatment of Coronary Bifurcation Lesions

  AUTHORS: Xing Huang, Ying Huang

  KEYWORDS: Coronary Bifurcation Lesion, Drug-Coated Balloon, DCB, PCI

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.14 No.2, February 11, 2026

  ABSTRACT: Coronary bifurcation lesions are anatomically complex and remain challenging in percutaneous coronary intervention (PCI), particularly in side-branch (SB) management and the prevention of in-stent restenosis (ISR). Drug-coated balloons (DCBs) based on the concept of “leave nothing behind” allow localized delivery of antiproliferative agents and inhibit neointimal hyperplasia, which offer novel therapeutic strategies for bifurcation lesions. This review summarizes the principles of DCB technology and the current evidence supporting their application in coronary bifurcation lesions, to inform optimal intervention procedures.